Perle Bioscience, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2013-05-18
- Employees
- 11
- Market Cap
- -
- Website
- http://perlebioscience.com
Clinical Trials
2
Active:0
Completed:0
Trial Phases
1 Phases
Phase 3:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 3
2 (100.0%)The Insulin Independence Trial (IIT) Evaluating the Safety and Efficacy of Oral Cyclosporine and Oral Lansoprazole for Insulin Independence Among Patients With Existing Type 1 Diabetes
Phase 3
Withdrawn
- Conditions
- Type 1 Diabetes
- Interventions
- Drug: Oral Cyclosporine and Oral LansoprazoleDrug: Placebos
- First Posted Date
- 2013-01-08
- Last Posted Date
- 2016-04-19
- Lead Sponsor
- Perle Bioscience, Inc.
- Registration Number
- NCT01762657
The Insulin Independence Trial (IIT) Evaluating the Safety and Efficacy of Oral Cyclosporine and Oral Omeprazole for Insulin Independence Among Recent Onset Type 1 Diabetes Patients
Phase 3
Withdrawn
- Conditions
- Type 1 Diabetes
- Interventions
- First Posted Date
- 2013-01-08
- Last Posted Date
- 2016-04-18
- Lead Sponsor
- Perle Bioscience, Inc.
- Registration Number
- NCT01762644
News
No news found